Wnt Signaling in Normal and Malignant Hematopoiesis

  1. Tannishtha Reya4
  1. 1Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710
  2. 2Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, North Carolina 27710
  3. 3Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  4. 4Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla, California 92093
  1. Correspondence: treya{at}ucsd.edu

Abstract

One of the most remarkable characteristics of stem cells is their ability to perpetuate themselves through self-renewal while concomitantly generating differentiated cells. In the hematopoietic system, stem cells balance these mechanisms to maintain steady-state hematopoiesis for the lifetime of the organism, and to effectively regenerate the system following injury. Defects in the proper control of self-renewal and differentiation can be potentially devastating and contribute to the development of malignancies. In this review, we trace the emerging role of Wnt signaling as a critical regulator of distinct aspects of self-renewal and differentiation, its contribution to the maintenance of homeostasis and regeneration, and how the pathway can be hijacked to promote leukemia development. A better understanding of these processes could pave the way to enhancing recovery after injury and to developing better therapeutic approaches for hematologic malignancies.



Also in this Collection

      | Table of Contents

      In this Collection